Company / strategic investorRegistered location :Schaffhausen

BB Biotech AGDeclared Swiss shareholdings

BB Biotech AG: 0 Swiss companies with a declared holding. Latest filing: 15.07.2016.

Disclosure tracking · company alerts with Pro

Estimated value (CHF): —
Swiss companies held: 0
Largest position: —
12-month trend: Not determinable; 0 rate rises · 0 rate falls
Latest filing: 15.07.2016; Active since 1999

Declared Swiss portfolio

Latest declared rate per company

No active declared position.

How to read these figures?

Rates come from the 57 official filings published by SIX Exchange Regulation. A filing is only required when a threshold is crossed (3, 5, 10, 15, 20, 25, 33⅓, 50, 66⅔%): the actual position may have changed since.

Estimated value = shares held per the latest filing × latest CHF closing price. It is an indicative order of magnitude: the position may have changed without a new threshold being crossed, and holdings without a share count or a CHF price are not valued. Each company's mini-chart traces the successive declared rates.

This profile shows only what the declarant published. No external data is added to it.

Group structure

Shareholding disclosures are often filed jointly by several entities of the same group. The registry links them together: "Controls" lists the group entities declared alongside this shareholder, "Controlled by" the head entities. The figure is the number of joint disclosures, followed by the date of the most recent one.

Show group structure5 controlled by · 3 controls

Controlled by

Group entities that file jointly with this shareholder as its head.

Biotech Target N.V24 · 06.10.2008
Biotech Invest N.V., -Curacao, Niederländische Antillen3 · 24.09.2004
Biotech Growth N.V., -Curacao, Netherlands Antilles1 · 21.06.2006
Biotech Invest S.A1 · 10.07.2001
Biotech Target SA Panama1 · 29.12.1999

Controls

Group entities linked to this shareholder in joint disclosures.

Biotech Target N.V22 · 15.07.2016
Biotech Invest N.V2 · 20.04.2013
Biotech Growth NV1 · 04.03.2010

This mapping reflects observed disclosures; it does not necessarily indicate permanent legal control.

Disclosure behaviour

Upward and downward threshold crossings show direction, without measuring daily trades below legal thresholds.

90 days · Upward crossings

visible history: 24

90 days · Downward crossings

visible history: 0

First disclosure: 24.02.1999Last disclosure: 15.07.2016

Nature of disclosed positions

Derivatives, sale positions or lending may indicate a more complex strategy than a long equity holding.

Equity holdings

Rights / derivatives

Latest shareholding disclosures

Below thresholdShareholdings

BB Biotech AG

BB Biotech AG · Single shareholder

Declared Swiss portfolio

Group structure

Controlled by

Controls

Disclosure behaviour

Nature of disclosed positions

Latest shareholding disclosures

Follow BB Biotech AG’s disclosures

Common questions

Explore further

Recent insider purchases

Insider barometer